Author:
Yamamoto Yoko,Tsutsumi Yasuo,Yoshioka Yasuo,Kamada Haruhiko,Sato-Kamada Keiko,Okamoto Takayuki,Mukai Yohei,Shibata Hiroko,Nakagawa Shinsaku,Mayumi Tadanori
Reference28 articles.
1. Phase I study of recombinant tumor necrosis factor in cancer patients;Blick;Cancer Res.,1987
2. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone;Rosenberg;N. Engl. J. Med.,1987
3. The fate of interleukin-2 after in vivo administration;Donohue;J. Immunol.,1983
4. Human cytokines, tumor necrosis factor, and interferons: gene cloning, animal studies, and clinical trials;Bollon;J. Cell. Biochem.,1988
5. Influence of renal and hepatic failure on the pharmacokinetics of recombinant human granulocyte colony-stimulating factor (KRN8601) in the rat;Tanaka;Cancer Res.,1990
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献